C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2011
11/03/2011	US20110269747 Polyarylcarboxamides useful as lipid lowering agents
11/03/2011	US20110269745 6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
11/03/2011	US20110269733 Silent Desensitizers of Neuronal nAChR and Methods of Use Thereof
11/03/2011	US20110269705 Quinolone compound and pharmaceutical composition
11/03/2011	US20110265878 Dye comprising a chromophore to which an acyloin group is attached
11/03/2011	US20110265876 Novel anchoring ligands for sensitizers of dye-sensitized photovoltaic devices
11/03/2011	CA2793856A1 Tetrahydrobenzothiophene compound
11/02/2011	EP2383268A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
11/02/2011	EP2383267A1 Substituted sulfonamide derivatives
11/02/2011	EP2383259A1 New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds
11/02/2011	EP2382215A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
11/02/2011	EP2382206A2 Compounds and methods for the treatment of pain and other diseases
11/02/2011	EP2382205A2 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	EP2382190A1 Toluidine sulfonamides and their use as-inhibitors
11/02/2011	EP1960387B1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor
11/02/2011	EP1758883B1 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
11/02/2011	EP1732901B1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
11/02/2011	EP1626961B1 Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
11/02/2011	EP1100512B1 Use of thioarabinofuranosyl compounds
11/02/2011	CN102229565A Spirofluorene bisbenzoacridine organic semiconductor material, preparation method and use method thereof
11/01/2011	US8048893 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
11/01/2011	CA2649521C Novel piperazine compound, and use thereof as hcv polymerase inhibitor
11/01/2011	CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
11/01/2011	CA2473591C 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
11/01/2011	CA2409741C Tnf-.alpha. production inhibitors
10/2011
10/27/2011	WO2011132633A1 Substituted 5-hydroxypyrimidine-4-carboxamide compound
10/27/2011	WO2011132048A1 Heteroaryl compounds as pde10a inhibitors
10/27/2011	WO2011131748A2 Novel inhibitors
10/27/2011	WO2011131741A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors
10/27/2011	US20110263698 Proanthocyanidin of cashew apple, composition containing proanthocyanidin, and application thereof
10/27/2011	US20110263615 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/27/2011	US20110263614 Novel compounds
10/27/2011	US20110263566 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives and PBK Inhibitors Containing the Same
10/27/2011	US20110263560 Organic Compounds
10/27/2011	US20110263431 Pyrrole derivatives for use as plant growth regulators
10/27/2011	US20110263428 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
10/27/2011	US20110262388 Novel inhibitors
10/26/2011	EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011	EP2380876A1 1-heterodiene derivative and harmful organism control agent
10/26/2011	EP2379536A1 Novel microbiocides
10/26/2011	EP2379527A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation
10/26/2011	EP2379524A1 Serotonin 5-ht2b receptor inhibitors
10/26/2011	EP2379523A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
10/26/2011	EP2379521A1 Sulfamides as trpm8 modulators
10/26/2011	EP2379513A1 Heteroaryl compounds useful as raf kinase inhibitors
10/26/2011	EP2379496A1 Sulfonamides as trpm8 modulators
10/26/2011	EP2181985B1 Antiviral Agent
10/26/2011	EP2142538B1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
10/26/2011	EP2001848B1 Piperidines and related compounds for the treatment of dementia
10/26/2011	EP1846394B1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
10/26/2011	EP1518855B1 Diaminopyrimidinecarboxa mide derivative
10/26/2011	CN1980934B Novel indole derivatives as selective androgen receptor modulators (sarms)
10/26/2011	CN102227407A Hepatitis c virus inhibitors
10/26/2011	CN102225926A Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/26/2011	CN101070304B Quinoline derivatives and their use as mycrobacterial inhibitors
10/25/2011	US8044207 Pyridinoylpiperidines as 5-HT1F agonists
10/25/2011	US8044204 8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
10/25/2011	US8044097 Chroman derivatives
10/25/2011	US8044092 Therapeutic compounds
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/20/2011	WO2011129589A2 Group 4 metal compound of thiophene-fused cyclopentadienyl ligand tetrahydroquinoline derivative, and olefin polymerization using same
10/20/2011	WO2011127833A1 Benzoheterocyclic compounds, preparation methods and uses thereof
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257130 Compositions and Methods for Treatment of Renin-Angiotensin Aldosterone System (RAAS)- Related Disorders
10/20/2011	US20110253995 Material for organic electroluminescence device and organic electroluminescence device using the same
10/19/2011	EP2377854A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis C virus (HCV) inhibitors
10/19/2011	EP2377851A1 Isoquinoline derivative
10/19/2011	EP2376485A1 Pyrazine derivatives useful as inhibitors of atr kinase
10/19/2011	EP2376483A1 Polymorph ii of an antifungal compound
10/19/2011	EP2376482A1 Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
10/19/2011	EP2376475A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
10/19/2011	EP2376455A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
10/19/2011	EP2376454A2 Inhibitors of diacylglycerol acyltransferase
10/19/2011	EP2375904A1 Biaryl carboxamides
10/19/2011	EP2375899A1 Piperidine-containing compounds and use thereof
10/19/2011	EP1694334B1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
10/19/2011	EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102219774A Aromatic amine derivative, light-emitting element, light-emitting device, electronic device, and lighting device
10/19/2011	CN102219772A Cortex pseudolaricis acid complex with bioactivity and preparation method thereof
10/19/2011	CN102219725A Benzohetercyclic compound as well as preparation method and applications thereof
10/19/2011	CN101180296B Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
10/18/2011	US8039622 Melanocortin receptor agonists
10/18/2011	US8039498 Imidazole compounds
10/18/2011	US8039489 Guanidine-containing compounds useful as muscarinic receptor antagonists
10/18/2011	US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011	CA2590939C Aminopyrimidine compounds and methods of use
10/18/2011	CA2494049C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2419842C New aporphine esters and their use in therapy
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/13/2011	WO2011126903A2 Multisubstituted aromatic compounds as inhibitors of thrombin
10/13/2011	WO2011126224A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/13/2011	WO2011125680A1 Material for organic electroluminescent element, and organic electroluminescent element using same
10/13/2011	WO2011125317A1 Triazole derivative and pest control agent
10/13/2011	WO2011124930A1 P38 map kinase inhibitors
10/13/2011	WO2011123937A1 Kinase inhibitors and method of treating cancer with same
10/13/2011	WO2011082266A3 Substituted heterocyclic compounds

1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 523